Cerevel Therapeutics Holdings, Inc.·4

Apr 4, 4:26 PM ET

PF Equity Holdings 1 B.V. 4

4 · Cerevel Therapeutics Holdings, Inc. · Filed Apr 4, 2022

Insider Transaction Report

Form 4Exit
Period: 2022-03-31
Transactions
  • Other

    Common Stock

    [F1]
    2022-03-3127,349,2110 total
Footnotes (1)
  • [F1]Shares transferred to its parent entity, Pfizer Inc., for no cash consideration.
Signature
/s/Susan E. Grant, Attorney-in-fact on behalf of PF Equity Holdings 1 B.V.|2022-04-04

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT